Croatian longevity startup GlycanAge secures €3.9 million to advance personalized preventative care

Published on February 19, 2024

GlycanAge, a biotech startup pioneering the field of glycan biomarkers, announced the successful completion of its €3.9 million seed funding round, led by LAUNCHub Ventures and UK-based deep-tech fund Kadmos Capital. This marks a substantial leap forward in the company’s quest to redefine personalized preventative healthcare. The field of glycobiology, despite its potential, has historically…

This content is for members only. Visit the site and log in/register to read.

The post Croatian longevity startup GlycanAge secures €3.9 million to advance personalized preventative care appeared first on EU-Startups.

Continue reading on website
Other news

Meet the speakers of our AI Panel Discussion at this year’s EU-Startups Summit

February 19, 2024
On May 9-10 we’ll be hosting the 10-year anniversary of our annual EU-Startups Summit in sunny Malta! At the event we’ll have lots of exciting speakers, panel discussions, networking activities, pitch competitions and much more. The EU-Startups Summit will gather over 2,000 founders, startup enthusiasts and investors for two days of networking, inspiration and learning!… This content is for member

Bilbao-based WIVI Vision raises €4 million to improve visual health with gamified AI-based therapies

February 19, 2024
WIVI Vision, a company offering innovative solutions to improve visual efficiency and treat visual dysfunctions in diagnosis and subsequent recovery, announced the closing of a €4 million round of funding led by Adara Ventures, an early-stage venture capital firm that invests in deep tech companies with a European footprint, with participation from Hearstlab, Avançsa, Caixabank… This content is fo